EUVIMEDEUVIMED entdecken
Multizentrische StudieKlinische Studie

Impact of 18 F-FDG PET/MRI on Therapeutic Management of Women with Newly Diagnosed Breast Cancer: Results from a Prospective Double-Center Trial

Kai Jannusch, Lale Umutlu, Julian Kirchner, Nils-Martin Bruckmann, Janna Morawitz, Ken Herrmann, Wolfgang Peter Fendler, Ann-Kathrin Bittner, Oliver Hoffmann, Svjetlana Mohrmann, Eugen Ruckhäberle, Martin Stuschke und 11 weitere

Journal of Nuclear Medicine · 10.10.2024 · jnumed.124.268065

DOI: 10.2967/jnumed.124.268065 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Journal of Nuclear Medicine, online erschienen am 10.10.2024. Verfasst von Kai Jannusch und 22 weiteren Autor:innen. Beteiligte Einrichtung: Department of Diagnostic and Interventional Radiology, Medical Faculty, University of Dusseldorf, Dusseldorf, Germany. Hauptthemen laut MEDLINE: Fluorodeoxyglucose F18, Breast Neoplasms, Magnetic Resonance Imaging, Positron-Emission Tomography. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 30 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Fluorodeoxyglucose F18Breast NeoplasmsMagnetic Resonance ImagingPositron-Emission TomographyHumansFemaleMiddle AgedProspective StudiesAdultAgedMultimodal ImagingNeoplasm StagingRadiopharmaceuticalsAged, 80 and over

Stichwörter der Autor:innen

PET/MRIbreast cancerbreast imagingstaging

Substanzen

Fluorodeoxyglucose F18Radiopharmaceuticals

Autor:innen und Institutionen

  • Department of Diagnostic and Interventional Radiology, Medical Faculty, University of Dusseldorf, Dusseldorf, Germany.
  • Department of Diagnostic and Interventional Radiology and Neuroradiology, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.
  • Department of Diagnostic and Interventional Radiology, Medical Faculty, University of Dusseldorf, Dusseldorf, Germany; julian.kirchner@med.uni-duesseldorf.de.
  • Department of Nuclear Medicine, University of Duisburg-Essen, and German Cancer Consortium-University Hospital Essen, Essen, Germany.
  • Department of Gynecology and Obstetrics, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.
  • Department of Obstetrics and Gynecology, Medical Faculty, University of Dusseldorf, Dusseldorf, Germany.

Zitieren

APA

Jannusch, K., Umutlu, L., Kirchner, J., Bruckmann, N. M., Morawitz, J., Herrmann, K., Fendler, W. P., Bittner, A. K., Hoffmann, O., Mohrmann, S., Ruckhäberle, E., Stuschke, M., Schmid, W., Giesel, F., Häberle, L., Esposito, I., Budach, W., Grueneisen, J., Matuschek, C., …, & Buchbender, C. (2024). Impact of 18 F-FDG PET/MRI on Therapeutic Management of Women with Newly Diagnosed Breast Cancer: Results from a Prospective Double-Center Trial. Journal of Nuclear Medicine, jnumed.124.268065. https://doi.org/10.2967/jnumed.124.268065

Vancouver

Jannusch K, Umutlu L, Kirchner J, Bruckmann NM, Morawitz J, Herrmann K, et al. Impact of 18 F-FDG PET/MRI on Therapeutic Management of Women with Newly Diagnosed Breast Cancer: Results from a Prospective Double-Center Trial. Journal of Nuclear Medicine. 2024:jnumed.124.268065. doi:10.2967/jnumed.124.268065

BibTeX
@article{Jannusch2024,
  author = {Jannusch, Kai and Umutlu, Lale and Kirchner, Julian and Bruckmann, Nils-Martin and Morawitz, Janna and Herrmann, Ken and Fendler, Wolfgang Peter and Bittner, Ann-Kathrin and Hoffmann, Oliver and Mohrmann, Svjetlana and Ruckhäberle, Eugen and Stuschke, Martin and Schmid, Werner and Giesel, Frederik and Häberle, Lena and Esposito, Irene and Budach, Wilfried and Grueneisen, Johannes and Matuschek, Christiane and Kowall, Bernd and Stang, Andreas and Antoch, Gerald and Buchbender, Christian},
  title = {Impact of 18 F-FDG PET/MRI on Therapeutic Management of Women with Newly Diagnosed Breast Cancer: Results from a Prospective Double-Center Trial},
  journal = {Journal of Nuclear Medicine},
  year = {2024},
  pages = {jnumed.124.268065},
  doi = {10.2967/jnumed.124.268065}
}
Kostenlos starten →